Rosemary and a breakthrough blood test: The Alzheimer's research that has Bill Gates excited
Gates, who has a personal and emotional connection to the disease—his father, William Gates, passed away in 2020 after a long battle with Alzheimer's—said he is genuinely excited about the progress being made in prevention, early diagnosis, and effective treatment.
Bill Gates, who wrote about the first blood test approved by FDA to diagnose Alzheimer's, said that; "...breakthroughs like this will make earlier, easier diagnosis possible—bringing us closer to better treatments and, someday, a cure."
As reported by The New Indian Express (TNIE Online) last moth the FDA approved the world's first blood test that helps detection of Alzheimer's disease in May.
Among the latest breakthroughs aimed at treatment of this yet incurable disease, another emerging name is Rosmarinus officinalis also known as Rosemary herbs -- an aromatic evergreen herb native to the Mediterranean region.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
9 hours ago
- Time of India
Scared of needles? AstraZeneca launches FluMist Home nasal spray delivery
Are you one of those people whose whole world starts buzzing and spinning as soon as they see a needle? Well, your trypanophobia (phobia of needles) won't stand in the way of your getting a flu shot to protect your health this fall. How? AstraZeneca now allows Americans to skip the doctor's office and pharmacy lines for their flu vaccine, with no needle required. No phlebotomy, no lines, and way less 'omg-this-is-gonna-hurt.' It's FDA-approved, easy as sniff-and-spray, and ready to deliver – straight to your door. With the launch of FluMist Home, a program that delivers the flu nasal spray directly to your door, you can now get your flu shot sitting on the couch in your PJs. FluMist Home: The game-changer for couch-cruisers What's new this flu season? It's AstraZeneca's game-changer, called FluMist Home: the first-ever at-home nasal spray flu vaccine you can order online. FluMist is a nasal spray influenza vaccine that's been FDA-approved since 2003 and works just as well as the traditional flu shot in preventing infection and serious illness. Previously, you had to get it from a healthcare provider. But with FluMist Home, that has changed. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Beyond Text Generation: An AI Tool That Helps You Write Better Grammarly Install Now Undo Dr. Ravi Jhaveri, pediatric infectious disease specialist, told the NY Post, 'This will be the first time someone will be able to give themselves a flu vaccine right in their own home,' adding, 'While that may seem intimidating, this is an incredible milestone to make vaccines more accessible.' How safe is it to use at home To gain FDA permission, AstraZeneca conducted a study requiring users to self-administer, or give, to a child using provided instructions. The result: a 100% success rate. Each kit contains: Clear written instructions Instructional videos Access to a toll-free pharmacist call center A pharmacist chat feature for live support How FluMist works Visit and complete a medical screening questionnaire. If approved, you'll choose a delivery date. The vaccine arrives in an insulated package with cooling packs to keep it safe. A licensed provider reviews your info and verifies insurance. Shipping fee is around $8.99 (insurance usually covers the vaccine itself). Without insurance, GoodRx coupons can reduce costs to around $30. Your nasal spray arrives in chilled packaging. Keep it refrigerated if you're waiting. How to administer: Sniff one spritz per nostril, as per instructions. It comes with how-to videos, written directions, and pharmacist support just a click or call away. Dispose of the used sprayer using the prepaid envelope. Easy peasy! AstraZeneca even reports a 100% success rate in self-administration studies. The service is available in 34 states, with plans to expand further. If your state isn't included yet, flu spray is still available at clinics and pharmacies. Who can use FluMist Home? Adults aged 18 to 49 can self-administer. Parents or caregivers can give the spray to children aged 2 to 17. 'Giving the vaccine at home, to yourself or your children, makes protection more accessible, convenient, and better aligned with people's busy lives,' said Jhaveri to the NY Post. He added, 'If your little one fears needles, your doctor's appointments are hard to get, or you juggle work and school schedules, this might be the perfect choice this season.' However, it is not suitable for those over 50, pregnant, immunocompromised, or with certain conditions like asthma, egg allergy, aspirin use, or GBS history. You're advised to check with your doctor in case of worries. Why flu shots still matter The 2024-2025 flu season was one of the worst in 15 years, with over 47 million cases, 610,000 hospitalizations, and 27,000 deaths, including 216 children. Vaccination rates are slipping: among children under 18, fewer than half were vaccinated, down from 62.4% pre-pandemic. Jhaveri emphasized, 'I strongly encourage flu vaccination, whether you've done it before or not, it remains one of the most effective ways to prevent flu,' adding, 'Children face serious risks, like pneumonia or hospitalization, and 150-200 children die each season, many of whom were otherwise healthy.' He concluded, 'I recommend getting vaccinated by the end of October, before flu season ramps up. It's vital to protect yourself, your family, and your community. '
Time of India
19 hours ago
- Time of India
Doctor reveals how excessive liver problems can affect the brain
Image credits: Getty Images The liver is one of the largest and most important organs in the body. From filtering out toxins to transmitting nutrients and vitamins to the rest of the body, the organ is vital for the healthy maintenance of humans. However, when the liver is unable to filter out toxins from the blood or when the blood flow through the organ is blocked, the toxins build up in the body and can get into the brain. Now, in a video going viral on the internet, a doctor has revealed how this can be highly harmful to the body. The video has received over 1,007 likes. How do liver diseases affect brain health ? Image credits: Getty Images In the caption of the viral video, Dr Joseph Salhab, who goes by the name "thestomachdoc" and is a gastroenterologist, as per his Instagram bio explained how the process works. "Many people don't realize that cirrhosis, a severe form of chronic liver disease, can progress to a condition that can impact brain function: overt hepatic encephalopathy (OHE)," said the caption. Overt hepatic encephalopathy can cause symptoms such as confusion, tremors, personality changes and other symptoms that might not seem connected to liver function. The caption also added that Xifaxan is the first and only FDA approved medicine that reduces the risk of OHE recurrence in adults. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Beyond Text Generation: An AI Tool That Helps You Write Better Grammarly Install Now Undo "Today I want to educate you about a condition called overt hepatic hepatic encephalopathy also known as OHE," began the doctor. "OHE is a complication of cirrhosis and occurs when the liver sustains damage and loses its ability to remove toxins from the bloodstream, effectively causing toxins to accumulate and lead to impaired brain function" "This leads to a range of mental and physical symptoms that can significantly impact a person's well being. Symptoms associated with an episode of OHE can include confusion, disorientation, severe personality changes, changes in sleep patterns, tremors and more which on the surface level may not seem connected to a decline in liver function but that's why I always advice speaking to a doctor about all of your symptoms," explained the doc. Treating the disease requires a diagnosis of the underlying health condition and the most common medications prescribed by healthcare providers Rifaximin and lactulose.
Hans India
a day ago
- Hans India
Study explains why loss of smell is associated with Alzheimer's disease
New Delhi: Brain's immune cells may explain why a fading sense of smell is an early signal for Alzheimer's disease even before cognitive impairments manifest, according to a study. Researchers at DZNE and Ludwig-Maximilians-Universität München (LMU) in Germany revealed that the brain's immune response seems to fatally attack neuronal fibres crucial for the perception of odours. These olfactory dysfunctions arise because immune cells of the brain called "microglia" remove connections between two brain regions, namely the olfactory bulb and the locus coeruleus, they noted in the paper published in the journal Nature Communications. These findings, based on observations in mice and humans, including analysis of brain tissue and so-called PET scanning, may help to devise ways for early diagnosis and, consequently, early treatment. "The locus coeruleus regulates a variety of physiological mechanisms. These include, for example, cerebral blood flow, sleep-wake cycles, and sensory processing. The latter applies, in particular, also to the sense of smell," said Dr. Lars Paeger, a scientist at DZNE and LMU. "Our study suggests that in early Alzheimer's disease, changes occur in the nerve fibres linking the locus coeruleus to the olfactory bulb. These alterations signal to the microglia that affected fibres are defective or superfluous. Consequently, the microglia break them down," Paeger added. Specifically, the team found evidence of changes in the composition of the membranes of the affected nerve fibres: Phosphatidylserine, a fatty acid that usually occurs inside a neuron's membrane, had been moved to the outside. "Presence of phosphatidylserine at the outer site of the cell membrane is known to be an 'eat-me' signal for microglia. In the olfactory bulb, this is usually associated with a process called synaptic pruning, which serves to remove unnecessary or dysfunctional neuronal connections," explained Paeger. The findings could pave the way for the early identification of patients at risk of developing Alzheimer's, enabling them to undergo comprehensive testing to confirm the diagnosis before cognitive problems arise.
